Avid Bioservices Inc (CDMO)

[entdoc]

dawg, I was only "in and out" of DNDN. In late. Out too early on FDA initial action. Won't do that again! FDA is learning just like we are. The MAB/immunology field is the current vogue since DNA "dark matter" seems momentarily unmanageable. I'll opt for MAB genetic engineering for the near future.